NYU Langone Health Gender Care Probe
Analysis based on 14 articles · First reported May 12, 2026 · Last updated May 12, 2026
The criminal probe by the United States — United States Department of Justice into NYU Langone Health and other healthcare providers regarding gender-affirming care creates significant regulatory uncertainty and legal risk for the healthcare industry, particularly for institutions offering such services. This could lead to a chilling effect on the provision of gender-affirming care, impacting the financial stability and operational decisions of hospitals and clinics nationwide.
NYU Langone Health received a federal grand jury subpoena from the United States — United States Department of Justice, marking the first known criminal probe into a hospital for providing gender-affirming care to minors. The subpoena, issued by the United States Attorney's Office in the United States — United States District Court for the Northern District of California, seeks information on patients under 18 who received care since 2020 and the names of involved providers. This action is part of the Donald Trump administration's broader crackdown on transgender youth treatments, following an executive order that ended federal funding for such care. NYU Langone Health had already closed its transgender youth program in February due to the regulatory environment. The United States — United States Department of Justice had previously issued over 20 administrative subpoenas to various healthcare providers, some of which were quashed by judges. A federal judge in Texas recently ordered United States — Rhode Island to comply with one such administrative subpoena. LGBTQ+ groups, including the Christopher Street Project, have condemned these federal actions, citing concerns about patient privacy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard